Search

Search Constraints

You searched for: Author/Creator Botling, Johan

Search Results

1. 720 Targeting MARCO and IL-37R on anti-inflammatory macrophages in lung cancer blocks regulatory T cells and shift balance to support cytotoxic lymphocyte function. (9th November 2020)

2. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer. Issue 9 (8th April 2014)

3. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non–small-cell lung cancer. (June 2020)

5. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases. Issue 6 (30th August 2018)

6. Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. (1st October 2020)

7. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer. (3rd June 2020)

8. Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer. (January 2021)

9. Expression of scavenger receptor MARCO defines a targetable tumor‐associated macrophage subset in non‐small cell lung cancer. Issue 7 (13th May 2018)

10. FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response. (July 2021)